0 comments

Using pharmacogenetics for safer drug orders

  • Rick Mansour, M.D.
  • 06/10/2014

The SunriseTM platform is unique because we designed it to be a central nervous system of health care organizations. It constantly gathers, aggregates, evaluates and acts on information for optimal clinical decision support. Our clients are using these capabilities to integrate evidence-based information at the point of care. For example, a team at the U.S. National Institutes of Health Clinical Center (NIH CC) recently developed a program for Sunrise using pharmacogenetics, which evaluates genetic information to predict a patient’s response to medication. The goal was to provide newly available information at the point of care to help clinicians reduce the risk of adverse drug events. The Journal of American Medical Information Association (JAMIA)* featured this patient safety project in a recent article. Starting with safety checks for three drugs The NIH CC team wanted a tool to help clinicians as […]